West Virginia Launches "Don't Let Vaping Cloud It" Campaign

Aug.25.2023
West Virginia launches "Don't Let Vaping Cloud It" campaign in schools to educate students about the dangers of vaping.

West Virginia Launches Anti-Vaping Campaign in Schools

 

CHARLESTON, WV () — The West Virginia Department of Health and Human Resources' Bureau for Public Health and West Virginia Department of Education have joined forces to kick-start an anti-vaping campaign throughout the state's schools. Governor Jim Justice has decreed that the campaign, known as "Don't Let Vaping Cloud It," will run for the next three years.

 

The aim of the campaign is to educate students about the dangers of vaping and to prevent them from falling into the vaping trap. The evidence presented during the campaign will highlight the harmful effects of vaping and will be paired with a vaping prevention program called "CATCH My Breath."

 

Governor Justice expressed his concerns about the widespread issue of vaping, stating, "Vaping is a huge problem all over the country, and now we're setting out to actively educate our students about the extreme dangers associated with e-cigarettes. Our goal is to educate our students early and prevent them from falling into this dangerous vaping trap."

 

According to Dr. Matthew Christiansen, State Health Officer and Commissioner for DHHR's Bureau for Public Health, e-cigarette use is a significant problem among West Virginia youth, with approximately half of all high school students reporting using e-cigarettes in 2021. The "CATCH My Breath" curriculum has been shown to effectively increase knowledge of the dangers of e-cigarettes and reduce nicotine vaping and overall tobacco use among students.

 

The campaign will focus primarily on middle school students as data suggests that vape usage typically starts at the age of 14. State Superintendent of Schools, Michele L. Blatt, emphasized the need to address the issue of vaping among students, stating, "E-cigarette use in West Virginia schools can have profound impacts on the future of young people. Together with our partners, including school teachers and counselors, we aim to decrease vaping among our students and empower them to make informed decisions so they can lead healthier lives."

 

To support the implementation of the program, teachers, counselors, and other school staff who participate will be offered free classes to effectively teach students about vape prevention.

 

For more information about the "CATCH My Breath" program, visit https://catch.org/program/vaping-prevention/.

 

This article is copyright 2023 Nexstar Media Inc. All rights reserved.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
European Commission Publishes Tobacco Control Framework Evaluation, Says Smoking and Tobacco-Related Deaths Have Declined
The European Commission has published its evaluation of the EU tobacco control framework, assessing the effectiveness, efficiency and relevance of the Tobacco Products Directive and Tobacco Advertising Directive in protecting public health and ensuring the smooth functioning of the internal market.
Apr.03 by 2FIRSTS.ai
FDA nicotine pouch review delay report knocks tobacco shares lower
FDA nicotine pouch review delay report knocks tobacco shares lower
After Reuters reported before the market open that FDA reviews of nicotine pouch applications could face delays, shares of Philip Morris International, Turning Point Brands and British American Tobacco fell on April 1, underscoring the direct impact of U.S. regulatory signals on major tobacco companies and nicotine pouch expectations.
Apr.02
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
A meeting was held at the Department for Combating Economic Crimes under the General Prosecutor’s Office of Uzbekistan with representatives of British American Tobacco Uzbekistan. Participants included the department’s leadership, the Inspectorate for Regulation of the Alcohol and Tobacco Market, and business representatives.
May.09 by 2FIRSTS.ai
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
FDA Says It Will Not Take Enforcement Action Against Zone Nicotine Pouches Until Lawsuit Is Resolved
The U.S. Food and Drug Administration has told vape manufacturer Fontem US that it does not presently intend to take enforcement action against the company’s Zone nicotine pouches while litigation over the agency’s handling of the application remains unresolved.
Apr.07 by 2FIRSTS.ai
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem US, the maker and seller of Zone nicotine pouches, has voluntarily dismissed its lawsuit against the U.S. Food and Drug Administration, which it had accused of unfairly delaying its market application.
Mar.25 by 2FIRSTS.ai